AI Article Synopsis
- The Society of Interventional Radiology Foundation formed a panel to create a research plan focusing on obesity treatments in interventional radiology (IR).
- The panel included experts who assessed current obesity therapies, discussed the regulatory process, and pinpointed areas in IR bariatric research that need improvement.
- They concluded that achieving a weight loss of more than 8%-10% over 6-12 months should be the target for future IR weight loss therapies, recommending a controlled trial comparing IR interventions with sham treatments, along with behavioral therapy.
Article Abstract
The Society of Interventional Radiology Foundation commissioned a Research Consensus Panel to establish a research agenda on "Obesity Therapeutics" in interventional radiology (IR). The meeting convened a multidisciplinary group of physicians and scientists with expertise in obesity therapeutics. The meeting was intended to review current evidence on obesity therapies, familiarize attendees with the regulatory evaluation process, and identify research deficiencies in IR bariatric interventions, with the goal of prioritizing future high-quality research that would move the field forward. The panelists agreed that a weight loss of >8%-10% from baseline at 6-12 months is a desirable therapeutic endpoint for future IR weight loss therapies. The final consensus on the highest priority research was to design a blinded randomized controlled trial of IR weight loss interventions versus sham control arms, with patients receiving behavioral therapy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jvir.2021.05.029 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!